IST 622Alternative Names: A 132; A 132M; NSC 639830
Latest Information Update: 28 Nov 2000
At a glance
- Originator Ishihara Sangyo Kaisha
- Class Cytostatic antibiotics
- Mechanism of Action DNA topoisomerase inhibitors; RNA synthesis inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Cancer